Triamcinolone
Medication
corticosteroid
skin
Not medical advice. Check with your doctor or pharmacist before you start, stop or change the timing of anything you take.
How to use
What it’s for
Prescribed for inflamed, itchy steroid-responsive skin
When to take
FDA: the 0.1% ointment goes on two to three times daily
Take with
A thin film on the affected area only (FDA ointment)
Pros & cons
Pros
- FDA: a topical form and a long-acting injection exist
- HSA: two SG oral pastes are pharmacy-only, not rx
- FDA topical: local reactions reported infrequently
Cons
- FDA: skin thinning, striae and hypopigmentation
- FDA injection: anaphylaxis including death reported
- FDA: occlusive dressings raise local reaction rates
Sources
- HSA — Listing of Registered Therapeutic Products (data.gov.sg open dataset, 5,511 rows, cached in full and filtered locally) · read 2026-08-27
what it says
“13 triamcinolone rows: 11 read 'Prescription Only' and 2 read 'Pharmacy Only' — ORACORT E DENTAL PASTE (SIN04682P) and KENO ORAL PASTE 1 mg/g (SIN11853P). Forms: paste, cream, injection 10 and 40 mg/ml, nasal spray 55 mcg/dose.”
- US FDA label — Triamcinolone Acetonide Ointment (topical), Indications and Usage, via openFDA drug/label.json · read 2026-08-27
what it says
“Triamcinolone Acetonide Ointment is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.”
- US FDA label — Triamcinolone Acetonide Ointment (topical), Dosage and Administration, via openFDA drug/label.json · read 2026-08-27
what it says
“Apply a thin film of Triamcinolone Acetonide Ointment 0.025% to the affected area two to four times daily. Apply a thin film of the 0.1% or the 0.5% … two to three times daily.”
- US FDA label — Triamcinolone Acetonide Ointment (topical), Adverse Reactions, via openFDA drug/label.json · read 2026-08-27
what it says
“The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings … burning, itching, irritation, dryness … skin atrophy, striae … hypopigmentation”
- US FDA label — Triamcinolone Acetonide Injectable Suspension, Dosage and Administration, via openFDA drug/label.json · read 2026-08-27
what it says
“The initial dose of triamcinolone acetonide injectable suspension may vary from 2.5 mg to 100 mg per day depending on the specific disease entity being treated … Dosage is usually adjusted within the range of 40 mg to 80 mg”
- US FDA label — Triamcinolone Acetonide Injectable Suspension, dosing in multiple sclerosis, via openFDA drug/label.json · read 2026-08-27
what it says
“In the treatment of acute exacerbations of multiple sclerosis, daily doses of 160 mg of triamcinolone for a week followed by 64 mg every other day for one month are recommended.”
- US FDA label — Triamcinolone Acetonide Injectable Suspension, Contraindications, via openFDA drug/label.json · read 2026-08-27
what it says
“Triamcinolone acetonide injectable suspension is contraindicated in patients who are hypersensitive to any components of this product … Intramuscular corticosteroid preparations are contraindicated for idiopathic thrombocytopenic purpura.”
- US FDA label — Triamcinolone Acetonide Injectable Suspension, Warnings, via openFDA drug/label.json · read 2026-08-27
what it says
“Cases of serious anaphylaxis, including death, have been reported … Exposure to excessive amounts of benzyl alcohol has been associated with toxicity … particularly in neonates … supportive dosage may be required … for a year afterwards”
Updated 2026-08-29. Every line above traces to a numbered source. Kozen-X is not a medical device and does not give medical advice. It lists what published sources have written down — nothing more. A pair not listed is unrecorded, not cleared. Before you start, stop or re-time anything, talk to your doctor or pharmacist.